TTM
−$7.11
YoY change
+66.2%
5Y CAGR
—
Peak year (2017)
−$0.85
Latest annual
−$5.95
EPS (Diluted) history chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: −$5.95
EPS (Diluted) growth chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: +66.2%
EPS (Diluted) history table for Revolution Medicines (RVMD) from 2017 to 2025
| 2025 | −$5.95 | +66.2% | −$2.37 | ||
| 2024 | −$3.58 | -7.3% | +$0.28 | ||
| 2023 | −$3.86 | +25.3% | −$0.78 | ||
| 2022 | −$3.08 | +24.7% | −$0.61 | ||
| 2021 | −$2.47 | +52.5% | −$0.85 | ||
| 2020 | −$1.62 | +23.7% | −$0.31 | ||
| 2019 | −$1.31 | +13.9% | −$0.16 | ||
| 2018 | −$1.15 | +35.3% | −$0.30 | ||
| 2017 | −$0.85 | — | — |
- 2025−$5.95+66.2%
- 2024−$3.58-7.3%
- 2023−$3.86+25.3%
- 2022−$3.08+24.7%
- 2021−$2.47+52.5%
- 2020−$1.62+23.7%
- 2019−$1.31+13.9%
- 2018−$1.15+35.3%
- 2017−$0.85—
EPS (Diluted) values are taken from Revolution Medicines's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Revolution Medicines (RVMD)
According to Revolution Medicines's latest reported financial statements, the company's current diluted EPS (TTM) is −$7.11. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual diluted EPS for Revolution Medicines (RVMD) came in at −$5.95 – surged 66.2% year-over-year.
The record annual diluted EPS stands at −$0.85, reached in 2017; the historical low of −$5.95 was recorded in 2025.
Revolution Medicines EPS (Diluted) by Year
Revolution Medicines EPS (Diluted) 2025: −$5.95
2025's diluted EPS for Revolution Medicines came in at −$5.95, surged 66.2% from 2024. This figure represents the lowest annual value in the available history.
Revolution Medicines EPS (Diluted) 2024: −$3.58
Revolution Medicines posted diluted EPS of −$3.58 in 2024, declined 7.3% below 2023.
Revolution Medicines EPS (Diluted) 2023: −$3.86
In 2023, Revolution Medicines reported diluted EPS of −$3.86, grew 25.3% from 2022.
Revolution Medicines EPS (Diluted) 2022: −$3.08
Revolution Medicines diluted EPS in 2022 was −$3.08, grew 24.7% from 2021.
Revolution Medicines EPS (Diluted) 2021: −$2.47
Revolution Medicines diluted EPS in 2021 was −$2.47.
See more financial history for Revolution Medicines (RVMD). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Revolution Medicines (RVMD), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Revolution Medicines (RVMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation